Dr Jeffrey J Harrison, DO | |
4700 Point Fosdick Dr Ste 202, Gig Harbor, WA 98335-1706 | |
(253) 858-9192 | |
(253) 857-1489 |
Full Name | Dr Jeffrey J Harrison |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 28 Years |
Location | 4700 Point Fosdick Dr Ste 202, Gig Harbor, Washington |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1194773135 | NPI | - | NPPES |
1043221 | Medicaid | WA | |
8939224 | Other | WA | STATE CRIME VICTIMS |
0189805 | Other | WA | STATE L&I |
P00209102 | Other | WA | RAILROAD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | OP00001673 (Washington) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
St Anthony Hospital | Gig harbor, WA | Hospital |
Harrison Medical Center | Bremerton, WA | Hospital |
Tacoma General Allenmore Hospital | Tacoma, WA | Hospital |
St Joseph Medical Center | Tacoma, WA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Franciscan Medical Group | 0547173866 | 1115 |
News Archive
Scancell Holdings Plc,, the developer of therapeutic cancer vaccines, today announces the enrolment and treatment of the first patient in its multicentre Phase I clinical trial of SCIB1, its DNA ImmunoBody® vaccine being developed for the treatment of melanoma. The trial will evaluate the safety and tolerability of SCIB1 in patients with late stage melanoma.
Medtronic, today announced that the U.S. Food and Drug Administration approved its Revo MRI SureScan pacing system, the first and only pacemaker in the U.S. specifically designed for use in an Magnetic Resonance Imaging environment and approved as MR-Conditional. Shipments of Revo MRI will begin immediately.
Sustaining a concussion during adolescence may be more common than previous estimates, according to researchers presenting their study at the American Orthopaedic Society for Sports Medicine's Annual Meeting in Colorado Springs, CO today.
New studies have shown that measles can compromise the immune system's ability to fight off other future infections.
› Verified 7 days ago
Entity Name | Franciscan Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093165334 PECOS PAC ID: 0547173866 Enrollment ID: O20031111000789 |
News Archive
Scancell Holdings Plc,, the developer of therapeutic cancer vaccines, today announces the enrolment and treatment of the first patient in its multicentre Phase I clinical trial of SCIB1, its DNA ImmunoBody® vaccine being developed for the treatment of melanoma. The trial will evaluate the safety and tolerability of SCIB1 in patients with late stage melanoma.
Medtronic, today announced that the U.S. Food and Drug Administration approved its Revo MRI SureScan pacing system, the first and only pacemaker in the U.S. specifically designed for use in an Magnetic Resonance Imaging environment and approved as MR-Conditional. Shipments of Revo MRI will begin immediately.
Sustaining a concussion during adolescence may be more common than previous estimates, according to researchers presenting their study at the American Orthopaedic Society for Sports Medicine's Annual Meeting in Colorado Springs, CO today.
New studies have shown that measles can compromise the immune system's ability to fight off other future infections.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Jeffrey J Harrison, DO 4700 Point Fosdick Dr Ste 202, Gig Harbor, WA 98335-1706 Ph: (253) 858-9192 | Dr Jeffrey J Harrison, DO 4700 Point Fosdick Dr Ste 202, Gig Harbor, WA 98335-1706 Ph: (253) 858-9192 |
News Archive
Scancell Holdings Plc,, the developer of therapeutic cancer vaccines, today announces the enrolment and treatment of the first patient in its multicentre Phase I clinical trial of SCIB1, its DNA ImmunoBody® vaccine being developed for the treatment of melanoma. The trial will evaluate the safety and tolerability of SCIB1 in patients with late stage melanoma.
Medtronic, today announced that the U.S. Food and Drug Administration approved its Revo MRI SureScan pacing system, the first and only pacemaker in the U.S. specifically designed for use in an Magnetic Resonance Imaging environment and approved as MR-Conditional. Shipments of Revo MRI will begin immediately.
Sustaining a concussion during adolescence may be more common than previous estimates, according to researchers presenting their study at the American Orthopaedic Society for Sports Medicine's Annual Meeting in Colorado Springs, CO today.
New studies have shown that measles can compromise the immune system's ability to fight off other future infections.
› Verified 7 days ago
Dr. Joan E Halley, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4700 Point Fosdick Dr Ste 220, Gig Harbor, WA 98335 Phone: 253-851-5121 Fax: 253-851-3059 | |
James Lewis Patterson, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4700 Point Fosdick Dr Nw, #220, Gig Harbor, WA 98335 Phone: 253-851-5121 Fax: 253-851-3059 | |
Alexander Snowmassara, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4545 Point Fosdick Dr # 250, Gig Harbor, WA 98335 Phone: 253-530-8000 | |
Dr. Jan Ellen Grouse, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 8316 86th Ave Nw, Gig Harbor, WA 98332 Phone: 253-851-8194 Fax: 253-851-8195 | |
Jason Kittredge, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4700 Point Fosdick Dr Ste 102, Gig Harbor, WA 98335 Phone: 253-853-2050 Fax: 253-852-2711 | |
Veronica Hooper, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 4700 Point Fosdick Dr Nw, Gig Harbor, WA 98335 Phone: 253-530-8000 |